Mitochondrial l-2-hydroxyglutarate is a physiological signalling metabolite

Read full text
Authors: Ram P. Chakrabarty, Jonathan G. Van Vranken, Yuki Aoi, Taylor A. Poor, Gregory S. McElroy, Karthik Vasan, Shimaa H. A. Soliman, Marta Iwanaszko, Rogan A. Grant, Benjamin C. Howard, Colleen R. Reczek, Anjali D. Chandel
+17 more Michael Kahl, Zhaofa Xu, Kathryn A. Helmin, Qiushi Jin, Dongmei Wang, Peng Gao, Jenna L. E. Blum, Zachary L. Sebo, Feng Yue, Yongchao C. Ma, Shawn M. Davidson, Steven P. Gygi, Samuel E. Weinberg, Benjamin D. Singer, SeungHye Han, A Shilatifard, Navdeep S. Chandel
Cited by: 4
References: 106

Abstract

l-2-Hydroxyglutarate (l-2-HG) is a low-abundance metabolite in mammals because the mitochondrial enzyme l-2-HG dehydrogenase (L2HGDH) oxidizes l-2-HG to 2-oxoglutarate (2-OG) to prevent its accumulation1. In humans, a lack of L2HGDH activity leads to l-2-HG accumulation and causes l-2-hydroxyglutaric aciduria2. Thus, l-2-HG is often classified as a toxic metabolite2–5. However, whether l-2-HG has any physiological function is unclear. Here we investigate whether l-2-HG qualifies as a physiological signalling metabolite by testing three criteria: regulated levels, defined molecular targets and a measurable physiological function. We report that an increase in mitochondrial NADH/NAD+ ratio drives malate dehydrogenase 2 (MDH2) to reduce 2-OG into l-2-HG. Moreover, L2HGDH oxidizes l-2-HG back to 2-OG in the mitochondrial matrix without requiring a functional electron transport chain. Through proteome integral solubility alteration assays, we show that the KDM4 family of H3K9 demethylases are l-2-HG-responsive targets. l-2-HG represses the nascent transcription of specific genes in mouse embryonic stem cells and increases H3K9me3 (a repressive histone mark) at these loci. In vivo, early embryonic L2HGDH overexpression in mice systemically reduces l-2-HG levels, impairs postnatal growth, causes mortality and produces selective functional and histological renal vulnerabilities. In postnatal kidneys, this reduction in l-2-HG causes H3K9me3 loss at L1MdTf retrotransposons and their derepression, which coincides with the activation of the integrated stress response and inflammation pathways. Our findings establish mitochondrial l-2-HG as a physiological signalling metabolite and indicate that metabolites previously regarded as toxic may also have crucial physiological functions. l-2-Hydroxyglutarate is identified as a legitimate physiological signalling metabolite, and control of its levels is essential for postnatal growth and survival and correct renal development and function.

Fields of Study & Subjects

Biochemical Acid Research Studies Metabolism and Genetic Disorders Cancer Hypoxia and Metabolism

Publication details

Journal / source
Nature
Publisher
Springer Science and Business Media LLC
Volume
655
Issue
8124
Pages
1037–1047
Publication date
20 May 2026
Language
EN